A PET scan can help doctors spot cancer that has spread through the body. A doctor may request one during the melanoma diagnostic process if they suspect advanced melanoma cancer. A PET scan is an ...
Sayaka Blickenderfer is a medical and science editor and writer with more than 10 years of experience. She edits and prepares scientific manuscripts and grant proposals for submission. Jane Kim, MD, ...
Christy Carlson Romano is fighting her insurance to cover a cancer scan. Here’s what to do if you face the same fight.
PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...
Actress Christy Carlson Romano’s struggle to get insurance coverage for a PET scan after a concerning cancer screening has drawn attention to widespread prior authorization denials. Industry data ...
Positron emission tomography (PET) scans can detect cancer earlier than other imaging tests. But some types of cancer are harder to detect on a PET scan. In particular, they may miss cancers that ...
Karin Rexroad peeks through the bore of the PET-CT scanner at LMH Health. Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.
Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.
Hosted on MSN
Foods to Eat and Foods to Avoid Before a PET Scan
A positron emission tomography (PET) scan is a diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat disease.
WASHINGTON DC - JUNE 20, 2023 Jay Reinstein, who suffers from Alzheimer's, prepares to receive a PET scan at MedStar Georgetown University Hospital in Washington, DC. (Photo by Michael Robinson Chávez ...
A new study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results